{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T19:12:14Z","timestamp":1780341134382,"version":"3.54.1"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2013,1,13]],"date-time":"2013-01-13T00:00:00Z","timestamp":1358035200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1007\/s00296-012-2542-x","type":"journal-article","created":{"date-parts":[[2013,1,12]],"date-time":"2013-01-12T09:38:21Z","timestamp":1357983501000},"page":"1813-1819","source":"Crossref","is-referenced-by-count":8,"title":["The economic burden of the ankylosing spondylitis in the Czech Republic: comparison between 2005 and 2008"],"prefix":"10.1007","volume":"33","author":[{"given":"Alena","family":"Pet\u0159\u00edkov\u00e1","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom\u00e1\u0161","family":"Dole\u017eal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji\u0159\u00ed","family":"Klime\u0161","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milan","family":"Vocelka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liliana","family":"\u0160edov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jozef","family":"Kol\u00e1\u0159","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,1,13]]},"reference":[{"key":"2542_CR1","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1093\/rheumatology\/keh669","volume":"44","author":"A Keat","year":"2005","unstructured":"Keat A, Barkham N, Bhalla A, Gaffney K, Marzo-Ortega H, Paul S et al (2005) BSR guidelines for prescribing TNF-alpha blockers in adults with ankylosing spondylitis. report of a working party of the British Society for rheumatology. Rheumatology 44:939\u2013947","journal-title":"Rheumatology"},{"key":"2542_CR2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta11280","volume":"11","author":"C McLeod","year":"2007","unstructured":"McLeod C, Bagust A, Boland A, Dagenais P, Dickson R, Dundar Y et al (2007) Adalimumab, etanercept and infliximab for the treatment of ankylosing spondylitis: a systematic review and economic evaluation. Health Technol Assess 11:1\u2013158","journal-title":"Health Technol Assess"},{"issue":"Suppl","key":"2542_CR3","first-page":"4","volume":"78","author":"A Boonen","year":"2006","unstructured":"Boonen A, van der Linden SM (2006) The burden of ankylosing spondylitis. J Rheumatol 78(Suppl):4\u201311","journal-title":"J Rheumatol"},{"key":"2542_CR4","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1136\/ard.62.8.732","volume":"62","author":"A Boonen","year":"2003","unstructured":"Boonen A, van der Heijde D, Landewe R, Guillemin F, Rutten-van Molken M, Dougados M (2003) Direct costs of ankylosing spondylitis and its determinants: an analysis among three European countries. Ann Rheum Dis 62:732\u2013740","journal-title":"Ann Rheum Dis"},{"key":"2542_CR5","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1136\/ard.61.5.429","volume":"61","author":"A Boonen","year":"2002","unstructured":"Boonen A, van der Heijde D, Landewe R, Spoorenberg A, Shouten H, Rutten-van Molken M (2002) Work status and productivity costs due to ankylosing spondylitis: comparison of three European countries. Ann Rheum Dis 61:429\u2013437","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"2542_CR6","first-page":"499","volume":"24","author":"P Hanova","year":"2006","unstructured":"Hanova P, Pavelka K, Dostal C, Holcatova I, Pikhart H (2006) Epidemiology of rheumatoid arthritis, juvenile idiopathic arthritis and gout in two regions of the Czech Republic in a descriptive population-based survey in 2002\u20132003. Clin Exp Rheum 24(5):499\u2013507","journal-title":"Clin Exp Rheum"},{"issue":"7\u20138","key":"2542_CR7","first-page":"726","volume":"52","author":"K Pavelka","year":"2006","unstructured":"Pavelka K (2006) Early diagnosis of ankylosing spondylitis. Vnitr Lek 52(7\u20138):726\u2013729 Czech","journal-title":"Vnitr Lek"},{"issue":"4","key":"2542_CR8","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1136\/ard.2005.041137","volume":"65","author":"J Zochling","year":"2006","unstructured":"Zochling J, van der Heijde D, Burgos-Vargas R, Collantes E, Davis JC Jr, Dijkmans B et al (2006) ASAS\/EULAR recommendations for the management of ankylosing spondylitis. Ann Rheum Dis 65(4):442\u2013452","journal-title":"Ann Rheum Dis"},{"key":"2542_CR9","first-page":"30","volume":"1","author":"K Pavelka","year":"2004","unstructured":"Pavelka K, Stolfa J, Vencovsky J (2004) Supplement of standard protocol for treatment ofankylosing spondylitis. Ces Revmatol 1:30\u2013035 Czech","journal-title":"Ces Revmatol"},{"issue":"9","key":"2542_CR10","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1136\/ard.62.9.817","volume":"62","author":"J Braun","year":"2003","unstructured":"Braun J, Pham T, Sieper J, Davis J, van der Linden S, Dougados M et al (2003) International ASAS consensus statement for the use of the anti-tumour necrosis factor agents in patients with ankylosing spondylitis. Ann Rheum Dis 62(9):817\u2013824","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"2542_CR11","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1111\/j.1524-4733.2007.00252.x","volume":"11","author":"G Kobelt","year":"2006","unstructured":"Kobelt G, Sobocki P, Mulero J, Gratacos J, Pocovi A, Collantes-Estevez E (2006) The burden of ankylosing spondylitis in Spain. Value Health 11(3):408\u2013415","journal-title":"Value Health"},{"key":"2542_CR12","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1007\/s10067-008-0845-9","volume":"27","author":"S Forejtova","year":"2008","unstructured":"Forejtova S, Mann H, Stolfa J, Vedral K, Fenclova I, Nemethova D et al (2008) Factors influencing health status and disability of patients with ankylosing spondylitis in the Czech Republic. Clin Rheumatol 27:1005\u20131013","journal-title":"Clin Rheumatol"},{"key":"2542_CR13","first-page":"43","volume":"2","author":"O Sleglova","year":"2004","unstructured":"Sleglova O, Dusek J, Olejarova M, Hornatova H, Draska L, Vencovsky J (2004) Evaluation of status and quality of life in patients with ankylosing spondylitis\u2013\u2013validation of Czech versions of bath questionnaires\u2013\u2013BAS-G, BADAI and BASFI. Ces Revmatol 2:43\u201354 Czech","journal-title":"Ces Revmatol"},{"issue":"2","key":"2542_CR14","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/art.1780230202","volume":"23","author":"JF Fries","year":"1980","unstructured":"Fries JF, Spitz P, Kraines RG, Holman HR (1980) Measurement of patient outcome in arthritis. Arthr Rheum 23(2):137\u2013145","journal-title":"Arthr Rheum"},{"issue":"12","key":"2542_CR15","first-page":"2286","volume":"21","author":"S Garrett","year":"1994","unstructured":"Garrett S, Jetkinson T, Kennedy LG, Whitelock H, Gaisford P, Callin A (1994) A new approach to defining disease status in ankylosing spondylitis: the bath ankylosing spondylitis disease activity Index. J Rheumatol 21(12):2286\u20132291","journal-title":"J Rheumatol"},{"issue":"1","key":"2542_CR16","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1524-4733.2009.00660.x","volume":"13","author":"LP Garrison Jr","year":"2010","unstructured":"Garrison LP Jr, Mansley EC, Abbott TA, Bresnahan BW, Hay JW, Smeeding J (2010) Good research practices for measuring drug costs In cost-effectiveness analyses: a societal perspective: the Ispor drug cost task force report: part II. Value Health 13(1):8\u201313","journal-title":"Value Health"},{"key":"2542_CR17","unstructured":"[Price list of VZP, version 650. Health Insurance Companies]. http:\/\/www.vzp.cz\/poskytovatele\/ciselniky\/hromadne-vyrabene-lecive-pripravky-a-potraviny-pro-zvlastni-lekarske-ucely#archiv (accessed 19 September 2011) [Czech]"},{"issue":"8","key":"2542_CR18","doi-asserted-by":"crossref","first-page":"653","DOI":"10.2165\/11588380-000000000-00000","volume":"29","author":"A Larg","year":"2011","unstructured":"Larg A, Moss JR (2011) Cost-of-Illness Studies. A Guide to Critical Evaluation. Pharmacoeconomics 29(8):653\u2013671","journal-title":"Pharmacoeconomics"},{"issue":"4","key":"2542_CR19","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1111\/j.1524-4733.2007.00288.x","volume":"11","author":"AD Asselt van","year":"2008","unstructured":"van Asselt AD, Dirksen CD, Arntz A, Severens JL (2008) Difficulties in calculating productivity costs: work disability associated with borderline personality disorder. Value Health 11(4):637\u2013644","journal-title":"Value Health"},{"key":"2542_CR20","unstructured":"[Central bank exchange rate fixing \u2013averages]. http:\/\/www.cnb.cz\/en\/financial_markets\/foreign_exchange_market\/exchange_rate_fixing\/currency_average.jsp?code=EUR (accessed 5 June 2011) [Czech]"},{"key":"2542_CR21","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1093\/rheumatology\/kem296","volume":"47","author":"RM Ara","year":"2008","unstructured":"Ara RM, Packham JC, Haywood KL (2008) The direct costs associated with ankylosing spondylitis patients attending a UK secondary care rheumatology unit. Rheumatology 47:68\u201371","journal-title":"Rheumatology"},{"key":"2542_CR22","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1093\/rheumatology\/keh271","volume":"43","author":"G Kobelt","year":"2004","unstructured":"Kobelt G, Andlin-Sobocki P, Brophy S, Jonsson L, Calin A, Braun J (2004) The burden of ankylosing spondylitis and the cost-effectiveness of treatment with infliximab. Rheumatology 43:1158\u20131166","journal-title":"Rheumatology"},{"key":"2542_CR23","first-page":"289","volume":"33","author":"G Kobelt","year":"2006","unstructured":"Kobelt G, Andlin-Sobocki P, Maksymowych W (2006) Cost and quality of life of patients with ankylosing spondylitis in Canada. J Rheumatol 33:289\u2013295","journal-title":"J Rheumatol"},{"key":"2542_CR24","doi-asserted-by":"crossref","first-page":"310","DOI":"10.3109\/03009740903544212","volume":"39","author":"P Hanova","year":"2010","unstructured":"Hanova P, Pavelka K, Holcatova I, Pikhart H (2010) Incidence and prevalence of psoriatic arthritis, ankylosing spondylitis, and reactive arthritis in the first descriptive population-based study in the Czech Republic. Scand J Rheumatol 39:310\u2013317","journal-title":"Scand J Rheumatol"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-012-2542-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00296-012-2542-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-012-2542-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T11:21:41Z","timestamp":1559042501000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00296-012-2542-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1,13]]},"references-count":24,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2013,7]]}},"alternative-id":["2542"],"URL":"https:\/\/doi.org\/10.1007\/s00296-012-2542-x","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,1,13]]}}}